Top Authors

• Most frequent coverage on ARIA

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • Five Drug Makers with Pending Catalysts (Tue, Sep 1)

  More by Justin M. Hall on ARIA »
• 
  Alan Brochstein (713 followers)

  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)
  • Cancer Stocks: The Bleeding Slows (Mon, Jul 2)

  More by Alan Brochstein on ARIA »
• 
  Derek Lowe (132 followers)

  • Don't Bury Ariad's Patent Yet (Thu, Aug 27)
  • Ariad Pharma: Professors Patent Pathways and Possibly Profit? (Thu, Jun 18)
  • Ariad's 'Patent' Is Finally, Officially Dead (Thu, Apr 9)

  More by Derek Lowe on ARIA »

• Most followed authors on ARIA

• 
  Philip Davis (6116 followers)

  • Options Trader: August Retrospective (Sat, Aug 29)

  More by Philip Davis on ARIA »
• 
  Bespoke Investment Group (3581 followers)

  • Russell 3000 Stock Performance YTD (Fri, Feb 13)

  More by Bespoke Investment Group on ARIA »
• 
  SA Editor Rachael Granby (2024 followers)

  • Wall Street Breakfast: Must-Know News (Fri, Jul 31)

  More by SA Editor Rachael Granby on ARIA »

• Newest authors on ARIA

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • Five Drug Makers with Pending Catalysts (Tue, Sep 1)

  More by Justin M. Hall on ARIA »
• 
  The Burrill Report (208 followers)

  • Biotech Discounts Galore (Sun, Aug 9)

  More by The Burrill Report on ARIA »
• 
  VFC's Stock House (1161 followers)

  • Readers Ask: Adventrix, Ariad Pharmaceuticals (Thu, Oct 15)

  More by VFC's Stock House on ARIA »

• Most commented on ARIA

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • Five Drug Makers with Pending Catalysts (Tue, Sep 1)

  More by Justin M. Hall on ARIA »
• 
  Stockerblog (449 followers)

  • 12 Stem Cell Stocks - Updated (Mon, Mar 9)
  • Nine Stem Cell Stocks to Add to Your Portfolio (Tue, Oct 2)
  • Investing in Stem Cell Stocks: Growth Industry of the Future? (Wed, Feb 21)

  More by Stockerblog on ARIA »
• 
  Alan Brochstein (713 followers)

  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks: Tracking the Market (Mon, Jul 9)
  • Cancer Stocks: The Bleeding Slows (Mon, Jul 2)

  More by Alan Brochstein on ARIA »